Stockscreener 앱 받기
9.75
0.52%
0.05
시장 영업 전:
9.75
Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스
Will MeiraGTx Holdings PLC (MGTX) report negative Q1 earnings? What you should know - MSN
Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
MeiraGTx Holdings plc ($MGTX) President and CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (NASDAQ: MGTX) details pay and board votes for 2026 AGM - Stock Titan
MeiraGTx (MGTX) CMO amends Form 4 for 7,814 tax-withheld shares - Stock Titan
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? - MSN
MeiraGTx rises on upcoming phase 1 readout for gene therapy - MSN
DAVENPORT & Co LLC Purchases 7,000 Shares of MeiraGTx Holdings Plc (NASDAQ:MGTX) - 富途牛牛
Discipline and Rules-Based Execution in MGTX Response - Stock Traders Daily
Eli Lilly partner MeiraGTx regains rights for genetic eye disease drug from Johnson & Johnson - MSN
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
Here is Why MeiraGTx Holdings (MGTX) is One of the Best Growth Stocks Under $10 - Yahoo Finance
Perceptive lifts MeiraGTx (NASDAQ: MGTX) ownership to 12.6% with warrants - Stock Titan
MeiraGTx and Hologen Enter Material Definitive Agreements and Collaboration License for Neuro AI – April 2026 - Minichart
MeiraGTx and Hologen finalize collaboration and licensing agreements By Investing.com - Investing.com Nigeria
MeiraGTx and Hologen finalize collaboration and licensing agreements - Investing.com
MeiraGTx acquires J&J's XLRP investigational therapy - Eyes On Eyecare
MeiraGTx (NASDAQ: MGTX) details $200M Hologen CNS gene therapy pact - Stock Titan
MeiraGTx (MGTX) Perceptive funds gain $8 warrants and new shares - Stock Titan
Piper Sandler raises MeiraGTx stock price target to $30 on data - Investing.com Australia
Piper Sandler raises MeiraGTx stock price target to $30 on data By Investing.com - Investing.com Australia
MGTX Maintained by Piper Sandler -- Price Target Raised to $30 - GuruFocus
MeiraGTx (NASDAQ:MGTX) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
What is HC Wainwright's Forecast for MeiraGTx Q1 Earnings? - MarketBeat
Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $30 - Moomoo
MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Richard Giroux Sells 56,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock - MarketBeat
MeiraGTx CFO & COO Richard Giroux sells $572,320 in stock By Investing.com - Investing.com South Africa
MeiraGTx CFO & COO Richard Giroux sells $572,320 in stock - Investing.com
[144] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (MGTX) CFO sells 56,000 shares under 10b5-1 plan - Stock Titan
Genetic Medicines Co. Reveals Transformative 'Only-of-Its-Kind' AAV Therapy Milestone - Streetwise Reports
Latham & Watkins Represents MeiraGTx in US$100 Million Ordinary Shares Offering - Latham & Watkins LLP
MEIRAGTX HOLDINGS PLC : COMPANY ANNOUNCEMENT - marketscreener.com
H.C. Wainwright reiterates MeiraGTx stock rating on gene therapy progress By Investing.com - Investing.com India
H.C. Wainwright reiterates MeiraGTx stock rating on gene therapy progress - Investing.com
MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock? - Yahoo Finance
H.C. Wainwright Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
MeiraGTx Announces Public Equity Offering to Fund Growth - The Globe and Mail
MGTX Maintained by RBC Capital -- Price Target Raised to $24.00 - GuruFocus
0.14%
0.48%
자본화:
|
볼륨(24시간):